Zhende Medical(SH:603301) Sou Hu Cai Jing·2025-08-07 00:33Core Viewpoint - The stock of Zhendemedical (603301) has shown a decline in price and mixed capital flow, indicating potential volatility in the market [1][2]. Financial Performance - As of August 6, 2025, Zhendemedical's stock closed at 22.08 yuan, down 1.3% with a trading volume of 27,700 hands and a transaction amount of 61.39 million yuan [1]. - The company reported a main revenue of 992 million yuan for Q1 2025, a year-on-year increase of 2.87%, while the net profit attributable to shareholders was 51.24 million yuan, a decrease of 30.19% year-on-year [4]. - The company's gross profit margin stands at 34.28%, which is significantly lower than the industry average of 51.31% [4]. Capital Flow Analysis - On August 6, 2025, the net outflow of main funds was 5.89 million yuan, accounting for 9.6% of the total transaction amount, while retail investors saw a net inflow of 7.72 million yuan, representing 12.57% of the total [1]. - Over the past five days, the financing balance has increased, with a net financing purchase of 2.25 million yuan on August 6, 2025, contributing to a cumulative net purchase of 14.04 million yuan over three days [2]. Industry Comparison - Zhendemedical's total market value is 5.883 billion yuan, which is below the industry average of 11.525 billion yuan, ranking 59th out of 123 companies in the medical device sector [4]. - The company's price-to-earnings ratio (P/E) is 28.7, significantly lower than the industry average of 61.65, indicating a potentially undervalued stock [4]. Institutional Ratings - In the last 90 days, two institutions have rated Zhendemedical with a "buy" recommendation, and the average target price set by institutions is 27.13 yuan [5].